Anika Therapeutics Inc 32 Wiggins Avenuebedford Ma 01730 Pma Numberp090031 Supplement Numbers013 Date Received06 17 2022 Decision Date07 13 2022 Product Code Moz Advisory Committee Orthopedic Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Anika Therapeutics Inc 32 Wiggins Avenuebedford Ma 01730 Pma Numberp090031 Supplement Numbers013 Date Received06 17 2022 Decision Date07 13 2022 Product Code Moz Advisory Committee Orthopedic Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P090031S013 Anika Therapeutics, Inc.32 Wiggins Avenuebedford, MA 01730 PMA NumberP090031 Supplement NumberS013 Date Received06/17/2022 Decision Date07/13/2022 Product Code MOZ  Advisory Committee Orthopedic Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No	Monovisc High Molecular Weight Hyaluronan	2022-07-13